Announcements Trials

Browse Landscape

Status

Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 379 Neoplasms 336 Carcinoma, Non-Small-Cell Lung 297 Prostatic Neoplasms 250 Colorectal Neoplasms 223 Lung Neoplasms 195 Multiple Myeloma 155 Ovarian Neoplasms 142 Pancreatic Neoplasms 140 Neoplasm Metastasis 132 Leukemia, Myeloid, Acute 129 Melanoma 112 Squamous Cell Carcinoma of Head and Neck 96 Lymphoma 89 Carcinoma, Renal Cell 89 Stomach Neoplasms 87 Recurrence 87 Lymphoma, Non-Hodgkin 86 Endometrial Neoplasms 85 Brain Neoplasms 83 Carcinoma, Hepatocellular 82 Precursor Cell Lymphoblastic Leukemia-Lymphoma 81 Head and Neck Neoplasms 73 Glioma 73 Glioblastoma 73 Uterine Cervical Neoplasms 71 Sarcoma 69 Urinary Bladder Neoplasms 67 Hematologic Neoplasms 66 Leukemia, Lymphocytic, Chronic, B-Cell 65

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Oncogenic osteomalacia × 30 days × Clear all

NCT04783428 2026-06-03

Tumor-induced Osteomalacia Disease Monitoring Program

Ultragenyx Pharmaceutical Inc

Active not recruiting

Oncogenic osteomalacia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡